Curcumin: Total-Scale Analysis of the Scientific Literature
Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články, systematický přehled
PubMed
30970601
PubMed Central
PMC6480685
DOI
10.3390/molecules24071393
PII: molecules24071393
Knihovny.cz E-zdroje
- Klíčová slova
- VOSviewer, Web of Science, bibliometrics, biochemistry, cancer, citation analysis, curcumin, pharmacology,
- MeSH
- bibliometrie * MeSH
- data mining * MeSH
- kurkumin * chemie terapeutické užití MeSH
- lidé MeSH
- nádory * farmakoterapie patologie MeSH
- software * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- systematický přehled MeSH
- Názvy látek
- kurkumin * MeSH
The current study aimed to provide a comprehensive bibliometric overview of the literature on curcumin, complementing the previous reviews and meta-analyses on its potential health benefits. Bibliometric data for the current analysis were extracted from the Web of Science Core Collection database, using the search string TOPIC=("curcumin*"), and analyzed by the VOSviewer software. The search yielded 18,036 manuscripts. The ratio of original articles to reviews was 10.4:1. More than half of the papers have been published since 2014. The major contributing countries were the United States, China, India, Japan, and South Korea. These publications were mainly published in journals representing the following scientific disciplines: biochemistry, chemistry, oncology, and pharmacology. There was a significant positive correlation between the total publication count and averaged citations per manuscript for affiliations, but not for countries/regions and journals. Chemicals that were frequently mentioned in the keywords of evaluated curcumin publications included curcuminoids, resveratrol, chitosan, flavonoids, quercetin, and polyphenols. The literature mainly focused on curcumin's effects against cancer, inflammation, and oxidative stress. Cancer types most frequently investigated were breast, colon, colorectal, pancreatic, and prostate cancers.
Department of Pharmaceutical and Pharmacological Sciences University of Padova 35020 Padova Italy
Department of Pharmacognosy University of Vienna 1090 Vienna Austria
GLOBE Program Association Grandville MI USA
MEDFUTURE Research Center for Advanced Medicine 400037 Cluj Napoca Romania
Pharmaceutical Institute University of Bonn An der Immenburg 4 53121 Bonn Germany
School of Pharmacy University of Camerino 62032 Camerino Italy
The National Institute of Poultry Husbandry Harper Adams University Shropshire TF10 8NB UK
Zobrazit více v PubMed
Jayaprakasha G., Rao L.J.M., Sakariah K. Chemistry and biological activities of C. longa. Trends Food Sci. Technol. 2005;16:533–548. doi: 10.1016/j.tifs.2005.08.006. DOI
Lee W.-H., Loo C.-Y., Bebawy M., Luk F., Mason R.S., Rohanizadeh R. Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21st century. Curr. Neuropharmacol. 2013;11:338–378. doi: 10.2174/1570159X11311040002. PubMed DOI PMC
Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 2003;23:363–398. PubMed
Yeung A.W.K., Tzvetkov N.T., El-Tawil O.S., Bungǎu S.G., Abdel-Daim M.M., Atanasov A.G. Antioxidants: Scientific Literature Landscape Analysis. Oxid. Med. Cell. Longev. 2019;2019:8278454. doi: 10.1155/2019/8278454. PubMed DOI PMC
Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007;4:807–818. doi: 10.1021/mp700113r. PubMed DOI
Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A. Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005;280:5892–5901. doi: 10.1074/jbc.M404751200. PubMed DOI
Cole G., Yang F., Lim G., Cummings J., Masterman D., Frautschy S. A rationale for curcuminoids for the prevention or treatment of Alzheimer’s disease. Curr. Med. Chem. Immunol. Endocr. Metab. Agents. 2003;3:15–25. doi: 10.2174/1568013033358761. DOI
Ono K., Hasegawa K., Naiki H., Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer’s β-amyloid fibrils in vitro. J. Neurosci. Res. 2004;75:742–750. doi: 10.1002/jnr.20025. PubMed DOI
Ringman J.M., Frautschy S.A., Cole G.M., Masterman D.L., Cummings J.L. A potential role of the curry spice curcumin in Alzheimer’s disease. Curr. Alzheimer Res. 2005;2:131–136. doi: 10.2174/1567205053585882. PubMed DOI PMC
Tewari D., Stankiewicz A.M., Mocan A., Sah A.N., Tzvetkov N.T., Huminiecki L., Horbańczuk J.O., Atanasov A.G. Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs. Front. Aging Neurosci. 2018;10:3. doi: 10.3389/fnagi.2018.00003. PubMed DOI PMC
Hatcher H., Planalp R., Cho J., Torti F., Torti S. Curcumin: From ancient medicine to current clinical trials. Cell. Mol. Life Sci. 2008;65:1631–1652. doi: 10.1007/s00018-008-7452-4. PubMed DOI PMC
Sharma R., Gescher A., Steward W. Curcumin: The story so far. Eur. J. Cancer. 2005;41:1955–1968. doi: 10.1016/j.ejca.2005.05.009. PubMed DOI
Yeung A.W.K. Sex differences in brain responses to food stimuli: A meta-analysis on neuroimaging studies. Obes. Rev. 2018;19:1110–1115. doi: 10.1111/obr.12697. PubMed DOI
Yeung A.W.K., Goto T.K., Leung W.K. Basic taste processing recruits bilateral anteroventral and middle dorsal insulae: An activation likelihood estimation meta-analysis of fMRI studies. Brain Behav. 2017;7:e00655. doi: 10.1002/brb3.655. PubMed DOI PMC
Yeung A.W.K., Goto T.K., Leung W.K. Brain responses to stimuli mimicking dental treatment among non-phobic individuals: A meta-analysis. Oral Dis. 2017 doi: 10.1111/odi.12819. PubMed DOI
Yeung A.W.K., Goto T.K., Leung W.K. Affective value, intensity and quality of liquid tastants/food discernment in the human brain: An activation likelihood estimation meta-analysis. Neuroimage. 2018;169:189–199. doi: 10.1016/j.neuroimage.2017.12.034. PubMed DOI
Sahebkar A., Cicero A.F., Simental-Mendía L.E., Aggarwal B.B., Gupta S.C. Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials. Pharmacol. Res. 2016;107:234–242. doi: 10.1016/j.phrs.2016.03.026. PubMed DOI
Daily J.W., Yang M., Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: A systematic review and meta-analysis of randomized clinical trials. J. Med. Food. 2016;19:717–729. doi: 10.1089/jmf.2016.3705. PubMed DOI PMC
Sahebkar A. A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clin. Nutr. 2014;33:406–414. doi: 10.1016/j.clnu.2013.09.012. PubMed DOI
Yeung A.W.K., Heinrich M., Atanasov A.G. Ethnopharmacology—A Bibliometric Analysis of a Field of Research Meandering Between Medicine and Food Science? Front. Pharmacol. 2018;9:215. doi: 10.3389/fphar.2018.00215. PubMed DOI PMC
Yeung A.W.K. Bibliometric study on functional magnetic resonance imaging literature (1995–2017) concerning chemosensory perception. Chemosens. Percept. 2018;11:42–50. doi: 10.1007/s12078-018-9243-0. DOI
Yeung A.W.K., Tzvetkov N.T., Atanasov A.G. When neuroscience meets pharmacology: A neuropharmacology literature analysis. Front. Neurosci. 2018;12:852. doi: 10.3389/fnins.2018.00852. PubMed DOI PMC
Yeung A.W.K., Mocan A., Atanasov A.G. Let food be thy medicine and medicine be thy food: A bibliometric analysis of the most cited papers focusing on nutraceuticals and functional foods. Food Chem. 2018;269:455–465. doi: 10.1016/j.foodchem.2018.06.139. PubMed DOI
Yeung A.W.K., El-Demerdash A., Berindan-Neagoe I., Atanasov A.G., Ho Y.-S. Molecular Responses of Cancers by Natural Products: Modifications of Autophagy Revealed by Literature Analysis. Crit. Rev. Oncog. 2018;23:347–370. doi: 10.1615/CritRevOncog.2018027566. PubMed DOI
Van Eck N.J., Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2009;84:523–538. doi: 10.1007/s11192-009-0146-3. PubMed DOI PMC
Patil T., Srinivasan M. Hypocholesteremic effect of curcumin in induced hypercholesteremic rats. Indian J. Exp. Biol. 1971;9:167–169. PubMed
Rao D.S., Sekhara N.C., Satyanarayana M., Srinivasan M. Effect of curcumin on serum and liver cholesterol levels in the rat. J. Nutr. 1970;100:1307–1315. doi: 10.1093/jn/100.11.1307. PubMed DOI
Bayet-Robert M., Morvan D. Metabolomics reveals metabolic targets and biphasic responses in breast cancer cells treated by curcumin alone and in association with docetaxel. PLoS ONE. 2013;8:e57971. doi: 10.1371/journal.pone.0057971. PubMed DOI PMC
Wang J., Zhang J., Zhang C.-J., Wong Y.K., Lim T.K., Hua Z.-C., Liu B., Tannenbaum S.R., Shen H.-M., Lin Q. In situ proteomic profiling of curcumin targets in HCT116 colon cancer cell line. Sci. Rep. 2016;6:22146. doi: 10.1038/srep22146. PubMed DOI PMC
Masoumi A., Goldenson B., Ghirmai S., Avagyan H., Zaghi J., Abel K., Zheng X., Espinosa-Jeffrey A., Mahanian M., Liu P.T. 1α, 25-dihydroxyvitamin D 3 Interacts with Curcuminoids to Stimulate Amyloid-β Clearance by Macrophages of Alzheimer’s Disease Patients. J. Alzheimers Dis. 2009;17:703–717. doi: 10.3233/JAD-2009-1080. PubMed DOI
Karlstetter M., Lippe E., Walczak Y., Moehle C., Aslanidis A., Mirza M., Langmann T. Curcumin is a potent modulator of microglial gene expression and migration. J. Neuroinflamm. 2011;8:125. doi: 10.1186/1742-2094-8-125. PubMed DOI PMC
Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., Marczylo T.H., Morgan B., Hemingway D., Plummer S.M. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin. Cancer Res. 2004;10:6847–6854. doi: 10.1158/1078-0432.CCR-04-0744. PubMed DOI
Dhillon N., Aggarwal B.B., Newman R.A., Wolff R.A., Kunnumakkara A.B., Abbruzzese J.L., Ng C.S., Badmaev V., Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008;14:4491–4499. doi: 10.1158/1078-0432.CCR-08-0024. PubMed DOI
Plummer S.M., Holloway K.A., Manson M.M., Munks R.J., Kaptein A., Farrow S., Howells L. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex. Oncogene. 1999;18:6013–6020. doi: 10.1038/sj.onc.1202980. PubMed DOI
Brouet I., Ohshima H. Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun. 1995;206:533–540. doi: 10.1006/bbrc.1995.1076. PubMed DOI
Anitha A., Maya S., Deepa N., Chennazhi K., Nair S., Tamura H., Jayakumar R. Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells. Carbohydr. Polym. 2011;83:452–461. doi: 10.1016/j.carbpol.2010.08.008. DOI
Das R.K., Kasoju N., Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine. 2010;6:153–160. doi: 10.1016/j.nano.2009.05.009. PubMed DOI
Surh Y.-J. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. Fundam. Mol. Mech. Mutagenes. 1999;428:305–327. doi: 10.1016/S1383-5742(99)00057-5. PubMed DOI
Yeung A.W.K., Goto T.K., Leung W.K. The Changing Landscape of Neuroscience Research, 2006–2015: A Bibliometric Study. Front. Neurosci. 2017;11:120. doi: 10.3389/fnins.2017.00120. PubMed DOI PMC
Ringman J.M., Frautschy S.A., Teng E., Begum A.N., Bardens J., Beigi M., Gylys K.H., Badmaev V., Heath D.D., Apostolova L.G., et al. Oral curcumin for Alzheimer’s disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimer’s Res. Ther. 2012;4:43. doi: 10.1186/alzrt146. PubMed DOI PMC
Kurd S.K., Smith N., VanVoorhees A., Troxel A.B., Badmaev V., Seykora J.T., Gelfand J.M. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial. J. Am. Acad. Dermatol. 2008;58:625–631. doi: 10.1016/j.jaad.2007.12.035. PubMed DOI PMC
Chainani-Wu N., Silverman S., Jr., Reingold A., Bostrom A., Mc Culloch C., Lozada-Nur F., Weintraub J. A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus. Phytomedicine. 2007;14:437–446. doi: 10.1016/j.phymed.2007.05.003. PubMed DOI
Panahi Y., Rahimnia A.R., Sharafi M., Alishiri G., Saburi A., Sahebkar A. Curcuminoid treatment for knee osteoarthritis: A randomized double-blind placebo-controlled trial. Phytother. Res. 2014;28:1625–1631. doi: 10.1002/ptr.5174. PubMed DOI
Panahi Y., Hosseini M.S., Khalili N., Naimi E., Simental-Mendía L.E., Majeed M., Sahebkar A. Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. Biomed. Pharmacother. 2016;82:578–582. doi: 10.1016/j.biopha.2016.05.037. PubMed DOI
Ganjali S., Sahebkar A., Mahdipour E., Jamialahmadi K., Torabi S., Akhlaghi S., Ferns G., Parizadeh S.M.R., Ghayour-Mobarhan M. Investigation of the effects of curcumin on serum cytokines in obese individuals: A randomized controlled trial. Sci. World J. 2014;2014:898361. doi: 10.1155/2014/898361. PubMed DOI PMC
Ryan J.L., Heckler C.E., Ling M., Katz A., Williams J.P., Pentland A.P., Morrow G.R. Curcumin for radiation dermatitis: A randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat. Res. 2013;180:34–43. doi: 10.1667/RR3255.1. PubMed DOI PMC
Peterson C.T., Vaughn A.R., Sharma V., Chopra D., Mills P.J., Peterson S.N., Sivamani R.K. Effects of turmeric and curcumin dietary supplementation on human gut microbiota: A double-blind, randomized, placebo-controlled pilot study. J. Evid.-Based Integr. Med. 2018;23 doi: 10.1177/2515690X18790725. PubMed DOI PMC
Kanai M., Otsuka Y., Otsuka K., Sato M., Nishimura T., Mori Y., Kawaguchi M., Hatano E., Kodama Y., Matsumoto S. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients. Cancer Chemother. Pharmacol. 2013;71:1521–1530. doi: 10.1007/s00280-013-2151-8. PubMed DOI
Greil R., Greil-Ressler S., Weiss L., Schönlieb C., Magnes T., Radl B., Bolger G.T., Vcelar B., Sordillo P.P. A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer. Cancer Chemother. Pharmacol. 2018;82:695–706. doi: 10.1007/s00280-018-3654-0. PubMed DOI PMC
Shoba G., Joy D., Joseph T., Rajendran M.M.R., Srinivas P. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64:353–356. doi: 10.1055/s-2006-957450. PubMed DOI
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Bioactive Molecules and Their Mechanisms of Action